KRAS and lung cancer: Another example would be the study carried out by Sussman et al., that reported a series of differentially expressed genes in subjects with lung cancer who had suffered a venous thromboembolic event, and that underscored those pathways related with the complement, inflammation and the KRAS signaling [45].